The Maurice Wohl Clinical Neuroscience Institute is set to be one of Europe’s leading centres for interdisciplinary neuroscience research and home to a unique cluster of neuroscience excellence. The Institute will bring together 250 clinicians and scientists and will be instrumental in fast-tracking new treatments for disorders such as Alzheimer’s disease, Parkinson’s disease, motor neurone disease, epilepsy and stroke.